ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

TYPHIM Vi
Vaccines
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

TYPHIM Vi Rx

Generic Name and Formulations:
Typhoid vaccine cell; surface purified Vi polysaccharide 25micrograms per 0.5mL; soln; for IM inj; contains phenol.

Company:
Sanofi Pasteur, Inc.

Therapeutic Use:

Indications for TYPHIM Vi:

Immunization against typhoid fever.

Adult:

Give at least 2 weeks before expected exposure; may repeat every 2 years. Adults: 0.5mL IM once in deltoid.

Children:

≥2yrs: 0.5mL in deltoid or vastus lateralis.

Contraindications:

Not for use in chronic carriers or patients with active infection.

Warnings/Precautions:

Have epinephrine (1:1000) inj available. Immunocompromised states. Previous typhoid vaccination. Thrombocytopenia. Coagulopathies. Acute infection. Active febrile illness. Exposure to contaminated food and water should be avoided. Pregnancy (Cat.C). Nursing mothers.

Adverse Reactions:

Local reactions, malaise, headache, GI upset, myalgia, fever.

How Supplied:

Syringe (0.5mL)—1
Multidose vials—contact manufacturer

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs